Americans pay less for generic drugs than Europeans due to fierce market competition, but far more for brand-name drugs because the U.S. funds global pharmaceutical innovation. Here's how the systems differ and why.
Americans pay less for generic drugs than Europeans due to fierce market competition, but far more for brand-name drugs because the U.S. funds global pharmaceutical innovation. Here's how the systems differ and why.